Is Shingrix approved for immunocompromised adults 18 and older?
Applies to Prevention of herpes zoster (shingles) in adults aged 18 years and older who are or will be at increased risk of herpes zoster due to immunodeficiency or immunosuppression caused by known disease or therapy
Note: The relative risks are pooled estimates from a meta-analysis of mostly observational studies (Marra et al., 2020); the footnote lists its limitations. The meta-analysis included people of all ages, so the estimates are not specific to adults 50 and older.
Shingrix: what is the lifetime risk of shingles?
Applies to Prevention of herpes zoster (shingles) in adults aged 50 years and older
Note: The 1 in 3 figure is a lifetime risk for people in general, cited on the Support for Nurses page of the Shingrix HCP site to a CDC clinical overview of shingles.
Shingrix: which immunocompromised adults are at increased risk of shingles?
Applies to Prevention of herpes zoster (shingles) in adults aged 18 years and older who are or will be at increased risk of herpes zoster due to immunodeficiency or immunosuppression caused by known disease or therapy
Note: The first four passages are from patient profiles (not actual patients) on the Patient Profiles page of the immunocompromised section of the Shingrix HCP site; the last is from its Patient Counseling page.